Symbiotec Pharmalab Limited SYMBIOTEC
NSE · updated 16 Oct 2026, 10:19 pm IST
BIG MONEY In this stock, the last 30 days
- On a run: up 5 sessions in a row, +17.7% in all.
From the exchange's bulk and block deal disclosures and NSE's daily file. The client's kind is read from its name. A record of trades, not a view on them. All big deals →
At a glance
Symbiotec Pharmalab Limited trades on the NSE under the symbol SYMBIOTEC. NSE's securities master records its listing date as 1 Sep 2026.
On 16 Oct 2026 the stock closed at ₹1,279.5, +2.0% on the day. Over the past year it has traded between ₹1,003.35 and ₹1,279.5; the current price sits 100% of the way up that range, 0.0% below the 52-week high — within striking distance of a new high. The move has been +17.7% over five sessions, +16.8% over a month.
Volume in the last session was 0.7× the stock's 20-session average. 40% of that volume was taken as delivery, against a 20-session average of 33%.
No promoter or insider trades have been filed for the stock in the last 90 days. No bulk or block deals were disclosed in the last 30 days.
| Face value | ₹2 |
| ISIN | INE899I01028 |
| 52-week range | ₹1,003.35 – ₹1,279.5 |
| 1-month return | +16.8% |
| Delivery (last session) | 40% (avg 33%) |
| Insider filings (90d) | 0 buy / 0 sell |
| Disclosed deals (30d) | 0 buy / 0 sell |
Price and delivery
Close price
Delivery % · 30-session average 30.7%
Delivery is the share of traded volume actually settled into demat accounts rather than squared off intraday — the difference between accumulation and churn. How it is used.
Bulk & block deals
Exchange-disclosed transactions, reported as published.
| Date | Client | Type | Qty | Price | Value |
|---|---|---|---|---|---|
| No deals disclosed. | |||||